6 civilians blast off to the edge of space on Blue Origin
Blue Origin launched its 13th crewed mission to the edge of space on Sunday morning, sending six civilian astronauts, including a married couple, past the Karman line and back in a little over 10 minutes.
The private space program's reusable New Shepard booster rocket ignited and cleared the launch pad tower in the West Texas desert and took about three-and-a-half minutes to travel the 62 miles to the Karman Line, the internationally recognized boundary of space.
The trip -- dubbed NS-33 for the 33rd New Shepard mission -- was originally planned for June 21 but had to be scrubbed twice due to the weather, Blue Origin officials said.
Passengers on the flight included Allie Kuehner, an environmentalist and conservationist, and Carl Kuehner, chairman of the real estate development company Building and Land Technology, who became the second married couple to travel aboard Blue Origin on the round-trip to the Karman line.
The trip marked the third suborbital human spaceflight for the Blue Origin New Shepard program since April 13, when an all-female crew that included singer Katy Perry, CBS News journalist Gayle King, and aviator Lauren Sanchez, who's now the wife of Blue Origin founder Jeff Bezos following their marriage Friday in Venice, Italy.
MORE: Video Blue Origin successfully launches its 12th crewed flight to space
Other space tourists aboard Sunday's Blue Origin flight were Leland Larson, a philanthropist and former CEO of an Oregon school bus transportation company; Freddie Rescigno Jr., president of a Georgia electrical cable company and a competitive golfer; and Jim Sitkin, a California attorney. Also on the flight was Owolabi Salis, an attorney and a financial consultant who became the first Nigerian-born person to go to space.
MORE: Blue Origin mission with all-female crew, including Katy Perry, completes space trip
The group lifted off from Blue Origin's Launch Site One, about 20 miles north of the West Texas town of Van Horn, at approximately 10:38 am ET.
Sunday's flight lasted about 10 minutes and 33 seconds, allowing the civilian crew a chance to unbuckle from their seats and briefly experience weightlessness in the capsule.
The New Shepard rocket, the company's fully reusable and fully autonomous spacecraft, separated from the capsule and returned to Earth ahead of the astronauts, safely descending and touching down on a landing pad not far from the launch site.
MORE: Blue Origin mission complete recap: Michael Strahan reflects on trip to space
At approximately 5 minutes and 20 seconds into the flight, the civilian astronauts returned to their seats for their journey back to terra firma. The capsule returned to Earth with the help of three giant parachutes.
Sunday's mission was the 13th human flight for the company's New Shepard program and the 33rd since Blue Origin was started in 2000 by Bezos, the 61-year-old billionaire founder of Amazon.
Seventy humans have now flown to space on Blue Origin since the company's first human flight in July 2021, according to the company.
ABC News' Matthew Glasser contributed to this report.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
an hour ago
- Washington Post
Did genes or ancestry make the Manning brothers? Why not both?
The field of sports genomics is rife with argument, starting with the simple question of what athleticism even is. For every study that shows a relationship between ribonucleic acids and raising trophies, another contradicts it. The interplay of slow- and fast-twitch fibers that makes balance, concentration, spatial awareness, these are not traits like hair color. Maybe someday genomics will be a useful predictor of whether you're growing a Hall of Famer at your kitchen table, but for the moment, it's overneat to the point of uselessness. If you're going down the rabbit hole of athleticism, at least go down a more intriguing path that embraces the messiness and mystery: genealogy.
Medscape
an hour ago
- Medscape
Respiratory Training Shows Modest Benefits in ALS
TOPLINE: Respiratory muscle training moderately improved lung function, especially respiratory muscle strength, in patients with amyotrophic lateral sclerosis (ALS) compared with no intervention or sham training. METHODOLOGY: Researchers conducted a meta-analysis to assess the effect of respiratory muscle training on lung function and respiratory muscle strength in patients with ALS. They gathered data from five randomized controlled trials including 170 patients with ALS (mean age range, 53-63 years; 58.8%-69.2% men), majority of whom had spinal onset of the disease (72.9%-84.6%). Researchers assessed the role of standalone respiratory muscle training and compared it with control conditions — physical exercise, usual care, or no intervention — to gauge its unique impact. The outcomes included assessments of lung function, respiratory muscle strength, survival, functional capacity, and adverse events. TAKEAWAY: According to a meta-analysis of three trials, maximum expiratory pressure was superior in the group that underwent respiratory muscle training compared with control conditions (standardized mean difference [SMD], 19.53; P = .02). Similarly, respiratory muscle training significantly improved the maximum inspiratory pressure compared with control conditions (SMD, 13.96; P = .010). A meta-analysis of four trials found no significant difference in the forced vital capacity between the groups (SMD, 0.90; P = .14). No studies reported serious adverse effects, supporting respiratory muscle training as a safe intervention for patients with ALS. IN PRACTICE: 'RMT [respiratory muscle training] shows potential as an adjuvant intervention for patients with ALS,' the authors wrote. SOURCE: This study was led by María Jesús Benzo-Iglesias, Health Research Centre, Humanidades-498 Research Group, University of Almería, Almería, Spain. It was published online on June 09, 2025, in Therapeutic Advances in Respiratory Disease. LIMITATIONS: This study had a small sample size, which limited the generalizability of the findings. It comprised only five trials, which may have affected the findings' robustness and restricted the ability to perform sensitivity analyses. The wide CIs in the heterogeneity analysis indicated substantial heterogeneity. DISCLOSURES: This study did not receive any funding. The authors declared having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Gizmodo
an hour ago
- Gizmodo
Biologists Uncover Previously Unknown Structure Hiding Inside Human Cells
Even after decades of peering into cells, biologists are still finding surprises. In a twist, researchers at the University of Virginia and the National Institutes of Health uncovered a new organelle, dubbed the hemifusome. This tiny membrane-bound structure serves as a cellular recycling center and may hold the key to treating several genetic diseases. The research has been published in Nature Communications. 'This is like discovering a new recycling center inside the cell,' co-author Seham Ebrahim, a biophysicist at the University of Virginia, said in a statement. 'We think the hemifusome helps manage how cells package and process material, and when this process goes awry, it may contribute to diseases that affect many systems in the body.' Scientists had not previously identified the structure because it only appears when needed. But thanks to cryo-electron tomography—an imaging technique that flash-freezes cells and captures them in 3D and in near-atomic resolution—researchers were able to observe the ephemeral structure. The researchers say hemifusomes may aid in the formation of cellular vesicles, tiny sacs that shuttle and combine material throughout the cell. They might also help form other organelles composed of multiple vesicles, the study suggests. However, some evidence shows that hemifusomes do not participate in endocytosis, the traditional pathway by which cells engulf external material. 'You can think of vesicles like little delivery trucks inside the cell,' Ebrahim said in a statement. 'The hemifusome is like a loading dock where they connect and transfer cargo. It's a step in the process we didn't know existed.' Despite their fleeting nature, hemifusomes are not rare. They appear to be surprisingly common in certain parts of cells, particularly near the cell membrane. Still, scientists aren't exactly sure how or why hemifusomes form and then disappear. They're hoping to find that out—as well as understand what happens when hemifusomes fail to function properly. Problems with how cells handle cargo are at the root of many genetic disorders. 'This is just the beginning,' Ebrahim said in a statement. 'Now that we know hemifusomes exist, we can start asking how they behave in healthy cells and what happens when things go wrong. That could lead us to new strategies for treating complex genetic diseases.'
